Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden hunger in MS: new study probes link between malnutrition and disability

NCT ID NCT07497126

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study measures how common malnutrition is in people with relapsing-remitting multiple sclerosis (RRMS) and whether it is linked to disability. Researchers will assess nutritional status, body composition, and other factors like depression and incontinence in 169 RRMS patients and compare them to healthy controls. No treatments are tested; the goal is to better understand the relationship between nutrition and MS disability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could highlight the need for nutritional screening in MS care, potentially improving quality of life through early dietary support.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply to all MS patients, and the link between malnutrition and disability may be complex.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

169 people

The number who actually took part.

Started

Nov 2024

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study population will consist of adults aged 18 years or older. The patient group will include individuals with relapsing-remitting multiple sclerosis who are followed in the neurology outpatient clinic of Antalya Training and Research Hospital and meet the predefined inclusion and exclusion criteria. A healthy control group of adult volunteers without multiple sclerosis will be recruited for comparison.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Diagnosis of relapsing-remitting multiple sclerosis for the patient group * Absence of another medical condition that markedly impairs walking, such as severe cardiovascular disease, respiratory disease, or major orthopedic conditions * Healthy volunteers willing to participate as controls * Written informed consent provided Exclusion Criteria: * EDSS score ≥7 in the relapsing-remitting multiple sclerosis group * Multiple sclerosis relapse during the last 30 days * Systemic glucocorticoid treatment during the last 30 days * History of musculoskeletal disease * History of neuromuscular junction disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malnutrition or risk of malnutrition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Antalya Training and Research Hospital

    Antalya, Antalya, 07100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.